MSCopilot, a new Multiple Sclerosis self-assessment digital solution: results of a comparative study versus standard tests.

Date publication

septembre 2019

Journal

European journal of neurology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme

Tous les auteurs :
Maillart E, Labauge P, Cohen M, Maarouf A, Vukusic S, Donzé C, Gallien P, De Sèze J, Bourre B, Moreau T, Louapre C, Mayran P, Bieuvelet S, Vallée M, Bertillot F, Klaeylé L, Argoud AL, Zinaï S, Tourbah A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31538396

Résumé

Assessing patients' disability in multiple sclerosis (MS) requires time-consuming batteries of hospital tests. MSCopilot is a software medical device for the self-assessment of patients with MS (PwMS), combining 4 tests: walking, dexterity, cognition, and low contrast vision. The objective was to validate MSCopilot versus Multiple Sclerosis Functional Composite (MSFC).

Mots clés

Health information technology, Mobile application, Multiple Sclerosis Functional Composite (MSFC), Multiple sclerosis, Reliability, Smartphone app, Validity, eHealth

Référence

Eur. J. Neurol.. 2019 Sep 20;: